These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. McCluggage WG Pathology; 2011 Aug; 43(5):420-32. PubMed ID: 21716157 [TBL] [Abstract][Full Text] [Related]
5. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
6. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
7. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor. Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory role of prohibitin in human ovarian epithelial cancer. Jia L; Ren JM; Wang YY; Zheng Y; Zhang H; Zhang Q; Kong BH; Zheng WX Int J Clin Exp Pathol; 2014; 7(5):2247-55. PubMed ID: 24966933 [TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma]. Zhang J; Li YH; Cui AR; Wang JL; Cheng JX; Wang SJ Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):905-9. PubMed ID: 19173990 [TBL] [Abstract][Full Text] [Related]
10. Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Behrens P; Rothe M; Florin A; Wellmann A; Wernert N Int J Mol Med; 2001 Aug; 8(2):149-54. PubMed ID: 11445865 [TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary]. Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types. Wang H; Rosen DG; Wang H; Fuller GN; Zhang W; Liu J Mod Pathol; 2006 Sep; 19(9):1149-56. PubMed ID: 16729015 [TBL] [Abstract][Full Text] [Related]
13. Nanog is highly expressed in ovarian serous cystadenocarcinoma and correlated with clinical stage and pathological grade. Pan Y; Jiao J; Zhou C; Cheng Q; Hu Y; Chen H Pathobiology; 2010; 77(6):283-8. PubMed ID: 21266826 [TBL] [Abstract][Full Text] [Related]
14. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related]
15. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. Ahmed N; Riley C; Rice GE; Quinn MA; Baker MS J Histochem Cytochem; 2002 Oct; 50(10):1371-80. PubMed ID: 12364570 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615 [TBL] [Abstract][Full Text] [Related]
17. Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases. Mansor S; McCluggage WG Int J Gynecol Pathol; 2014 Sep; 33(5):470-6. PubMed ID: 25083962 [TBL] [Abstract][Full Text] [Related]
19. [Expression of mesothelin mRNA and protein in ovarian carcinomas]. Bi SN; Dai SZ; Yao Q; Che YC; Wang N Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634 [TBL] [Abstract][Full Text] [Related]
20. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters. Lin CK; Chao TK; Yu CP; Yu MH; Jin JS APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]